GENTAUR Molecular Products.
Monoclonal Antibody, ELISA Kit, Polyclonal Antibody, Recombinant/Purified Protein.
GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc 6017 Snell Ave, Ste 357, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, sales@genprice.com
Index / Biovis / Daunorubicin.HCl / Product Detail : 1524-500 Daunorubicin.HCl
Related keywords:
Apr
26th
#1524-500 Daunorubicin.HCl
| Price : | 1554 | EUR |
| 1764 | USD | |
| 1205 | GBP | |
| 6529 | Zloty | |
| 207982 | JPY | |
| 11987 | NOK | |
| 12844 | SEK | |
| 1758 | CHF |
Product name : Daunorubicin.HCl
Catalog number : 1524-500
Quantity: 500 mg
Availability: Yes
Supplier name : Biovis
Data sheet: Ask more or other datasheet now !
More Details about
Alternate Name/Synonyms: Daunomycin hydrochloride
Appearance: Orange-red powder
Formulation: N/A
CAS Number: 23541-50-6
Molecular Formula: C₂₇H₂₉NO₁₀ · HCl
Molecular Weight: 563.98
Purity: >95%
Solubility: H₂O or MeOH
Storage Temp.: -20°C
Shipping Conditions: RT
Description: Potent anti-cancer agent whose potential target site may be mitochondrial cytochrome c oxidase. Inhibits RNA and DNA synthesis. Also inhibits eukaryotic topoisomerase I & II. Induces DNA single strand breaks and apoptosis in HeLaS3 tumor cells.
Handling: Protect from moisture
USAGE: For Research Use Only! Not For Use in Humans.
Contact us about this product :
Our team will respond you as soon as possible !
GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
Fax 0032 16 50 90 45
info@gentaur.com | Gentaur
GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur
GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50
Fax 01 43 25 01 60
RCS Paris B 484 237 888
SIRET 48423788800017
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
france@gentaur.com | Gentaur
GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88
Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur
GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com
Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123
GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel: 0208-080893 Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62 SWIFT RABONL2U
GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur
ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF
GENTAUR Poland Sp. z o.o.
ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX 058 710 33 48
poland@gentaur.com | Gentaur
Other countries
Österreich +43720880899
Canada Montreal +15149077481
Ceská republika Praha +420246019719
Danmark +4569918806
Finland Helsset +358942419041
Magyarország Budapest +3619980547
Ireland Dublin+35316526556
Luxembourg+35220880274
Norge Oslo+4721031366
Sverige Stockholm+46852503438
Schweiz Züri+41435006251
US New York+17185132983
GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo
Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur
Related products : Daunorubicin.HCl
Gentaurpub
WP1025: B Cell Receptor Signaling Pathway
WP1087: IL-5 Signaling Pathway
WP1144: B Cell Receptor Signaling Pathway
WP1315: IL-5 Signaling Pathway
WP1354: B Cell Receptor Signaling Pathway
WP151: IL-5 Signaling Pathway
WP2272: Pathogenic Escherichia coli infection
WP274: B Cell Receptor Signaling Pathway
WP285: B Cell Receptor Signaling Pathway
WP44: IL-5 Signaling Pathway
WP744: IL-5 Signaling Pathway
WP794: B Cell Receptor Signaling Pathway
WP849: IL-5 Signaling Pathway
WP908: B Cell Receptor Signaling Pathway
WP968: IL-5 Signaling Pathway
Related Genes :
[LYK3 HCL RLK3 MTR_5g086130] LysM domain receptor-like kinase 3 (LysM-containing receptor-like kinase 3) (MtLYK3) (EC 2.7.11.1) (LysM receptor kinase K1B) (Protein HAIR CURLING)
[COLEC12 CLP1 NSR2 SCARA4 SRCL] Collectin-12 (Collectin placenta protein 1) (CL-P1) (hCL-P1) (Nurse cell scavenger receptor 2) (Scavenger receptor class A member 4) (Scavenger receptor with C-type lectin)
[doxA] Cytochrome P-450 monooxygenase DoxA (EC 1.14.13.181) (13-deoxycarminomycin C-13 hydroxylase) (13-deoxydaunorubicin C-13 hydroxylase) (13-dihydrocarminomycin C-13 hydroxylase) (13-dihydrodaunorubicin C-13 hydroxylase) (Daunorubicin C-14 hydroxylase)
[COI] Cytochrome c oxidase subunit 1 (EC 1.9.3.1) (Fragment)
[AKR1B1 ALDR1] Aldose reductase (AR) (EC 1.1.1.21) (Aldehyde reductase) (Aldo-keto reductase family 1 member B1)
[] HERV-H_2q24.3 provirus ancestral Env polyprotein (Env protein HERV-H/p62) (Env protein HERV-H19) (Env protein HERV-Hcl.3) (Envelope polyprotein) (HERV-H/env62) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)]
[drrA] Daunorubicin/doxorubicin resistance ATP-binding protein DrrA (EC 3.6.3.-)
[linA] Gamma-hexachlorocyclohexane dehydrochlorinase (Gamma-HCH dehydrochlorinase) (EC 4.5.1.-)
[cytb] Cytochrome b
[doxA] Cytochrome P-450 monooxygenase DoxA (EC 1.14.13.181) (13-deoxycarminomycin C-13 hydroxylase) (13-deoxydaunorubicin C-13 hydroxylase) (13-dihydrocarminomycin C-13 hydroxylase) (13-dihydrodaunorubicin C-13 hydroxylase)
[MET17 MET15 MET25 YLR303W L8003.1] Homocysteine/cysteine synthase (EC 2.5.1.47) (EC 2.5.1.49) (O-acetylserine/O-acetylhomoserine sulfhydrylase) (OAS-OAH SHLase) (OAS-OAH sulfhydrylase)
[AW171_hschr31970] HCL051Cp
[dnrJ] Daunorubicin biosynthesis sensory transduction protein DnrJ
[COI] Cytochrome c oxidase subunit 1 (EC 1.9.3.1) (Fragment)
[COI] Cytochrome c oxidase subunit 1 (EC 1.9.3.1) (Fragment)
[COI] Cytochrome c oxidase subunit 1 (EC 1.9.3.1) (Fragment)
[COI] Cytochrome c oxidase subunit 1 (EC 1.9.3.1) (Fragment)
[COI] Cytochrome c oxidase subunit 1 (EC 1.9.3.1) (Fragment)
[COI] Cytochrome c oxidase subunit 1 (EC 1.9.3.1) (Fragment)
[COI] Cytochrome c oxidase subunit 1 (EC 1.9.3.1) (Fragment)
[COI] Cytochrome c oxidase subunit 1 (EC 1.9.3.1) (Fragment)
[COI] Cytochrome c oxidase subunit 1 (EC 1.9.3.1) (Fragment)
[COI] Cytochrome c oxidase subunit 1 (EC 1.9.3.1) (Fragment)
[COI] Cytochrome c oxidase subunit 1 (EC 1.9.3.1) (Fragment)
[COI] Cytochrome c oxidase subunit 1 (EC 1.9.3.1) (Fragment)
[COI] Cytochrome c oxidase subunit 1 (EC 1.9.3.1) (Fragment)
[COI] Cytochrome c oxidase subunit 1 (EC 1.9.3.1) (Fragment)
[COI] Cytochrome c oxidase subunit 1 (EC 1.9.3.1) (Fragment)
[COI] Cytochrome c oxidase subunit 1 (EC 1.9.3.1) (Fragment)
[COI] Cytochrome c oxidase subunit 1 (EC 1.9.3.1) (Fragment)
Bibliography :
[29690909] Targeting chemotherapy-resistant leukemia by combining DNT cellular therapy with conventional chemotherapy.
[29676467] Immunophenotypic analysis of cell cycle status in acute myeloid leukaemia: relationship to cytogenetics, genotype and clinical outcome.
[29673999] Ribociclib shows potential for pharmacokinetic drug-drug interactions being a substrate of ABCB1 and potent inhibitor of ABCB1, ABCG2 and CYP450 isoforms in vitro.
[29672160] Unlike Butylcycloheptylprodigiosin, Isolated Undecylprodigiosin from Streptomyces parvulus Is Not a MDR1 and BCRP Substrate in Multidrug-Resistant Cancers.
[29665909] [Complete Remission Rate and Adverse Ractions of Three Different Chemotherapy Regimens in the Treatment of Adult Patients with Newly Diagnosed Non-M3 AML].
[29658530] The comparative study of influence of lactic and glycolic acids copolymers type on properties of daunorubicin loaded nanoparticles and drug release.
[29656114] Synergistic Action of Dual IGF1/R and MEK Inhibition Sensitizes Childhood Acute Lymphoblastic Leukaemia (ALL) Cells to Cytotoxic Agents and Involves Down-Regulation of STAT6 and PDAP1.
[29650946] A Rare Case of Relapsed Pediatric Acute Promyelocytic Leukemia with Skin Involvement by Myeloid Sarcoma.
[29642189] Nonleukemic granulocytic sarcoma of orbit after blunt trauma: A case report and review of literature.
[29642164] Hydroa vacciniforme-like cutaneous T-cell lymphoma in a child: A case report.
Share this page:
Enter catalog number :
Favorites Pages:
No Favorits